alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Athens, Georgia
 close




            Search small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home People & Locations







Chance  O'Barr
                        Location Support Staff

                        




                        
                        Student Trainee
                        Phone: (706) 546-3416
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements of Choices Entertainment Corporation and is qualified in
its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         197,117
<SECURITIES>                                         0
<RECEIVABLES>                                    1,123
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               198,240
<PP&E>                                           4,034
<DEPRECIATION>                                     403
<TOTAL-ASSETS>                                 201,996
<CURRENT-LIABILITIES>                          524,938
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          1
<COMMON>                                       220,044
<OTHER-SE>                                   (597,222)
<TOTAL-LIABILITY-AND-EQUITY>                   201,996
<SALES>                                      2,115,622
<TOTAL-REVENUES>                             2,115,622
<CGS>                                          320,120
<TOTAL-COSTS>                                  320,120
<OTHER-EXPENSES>                             2,757,852
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              37,081
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (753,450)
<DISCONTINUED>                               1,040,223
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   286,772
<EPS-PRIMARY>                                     0.01
<EPS-DILUTED>                                     0.00


</TABLE>
Supreme Court ofthe United States

Office ofthe Clerk

Washington, DC 20543-0001

Scott S. Harris

Clerk of the Court

December 15, 2015 (202)479-3011

Clerk

Court of Criminal Appeals of Texas

P.O. Box 12308

Capitol Station

Austin, TX 78711

Re: Osmin Peraza

v. Texas

No. 15-7367

(Your No. PD-0100-15, PD-0101-15)

Dear Clerk:

The petition for a writ of certiorari in the above entitled case was filed on

December 11, 2015 and placed on the docket December 15, 2015 as No. 15-7367.

Sincerely,

Scott S. Harris, Clerk

by

Redmond K. Barnes

Case Analyst

RECEIVED IN COURT OF CRIMINAL APPEALS

DEC 28 2015

Abel Acosta, Clerk
EXHIBIT 14

ITRONICS INC.

CODE OF BUSINESS CONDUCT AND ETHICS

 

March 25, 2004

The Board of Directors of Itronics Inc. has adopted the following Codeof Business Conduct and Ethics (the Code). This Code is applicable to all directors,officers, and other senior management personnel (Management) of Itronics Inc. and itssubsidiaries. The purpose of this Code is to promote the highest standards of ethicalconduct of business.

> 
1. Management will practice honesty, integrity and good faith in every    aspect of dealing with other Company personnel, shareholders, the public, customers,    suppliers and government authorities. All persons are to be treated with dignity and    respect.

2. Management will respect and obey all applicable federal, state, and    local laws and regulations. Management will not only follow the letter of the law, but the    spirit as well. 

3. Management will do its utmost to avoid real or perceived conflicts    of interest in our business dealings. Apparent conflicts of interest are to be disclosed    to the appropriate person promptly. 

4. Management will prepare reports and other disclosures to be    disseminated to the public or to be filed with the Securities and Exchange Commission or    other governmental authorities in a full, fair, accurate, timely, and understandable    manner. The needs of our investors and the investing public will always be the foremost    priority in preparing such reports or disclosures.

5. Trading of the Company’s securities will be conducted under all    applicable laws and rules of the Securities and Exchange Commission. Management will not    take unfair advantage of any publicly undisclosed information it may have regarding the    operations of the Company and its subsidiaries. 

6. Each member of Management is responsible to conduct him or herself    in accordance with this Code. Any observed violations are to be reported to the    appropriate person promptly. Violations of this Code subject the individual to    disciplinary action and possible termination.

7. Management includes directors, the principal executive officer, the    principal accounting officer or controller, or employees performing similar functions. 

 

The appropriate person to discuss any questions about this Code,  observed violations of the Code, or potential conflicts of interest is the principal  executive officer, which is currently the President of the Company. 

79

----
# EUR-Lex - 52006IP0416 - EN

Important legal notice

*|*

# 52006IP0416

**European Parliament resolution on future patent policy in Europe **

*
Official Journal 308 E , 16/12/2006 P. 0169 - 0169 *

P6_TA(2006)0416

Future action in the field of patents

European Parliament resolution on future patent policy in Europe

The European Parliament,

- having regard to the Commission's Green Paper of 24 June 1997 on the Community patent and the patent system in Europe — Promoting innovation through patents (COM(1997)0314),

- having regard to Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions [1],

- having regard to its resolution of 26 October 2005 on patents on biotechnological inventions [2],

- having regard to the consultation launched by the Commission on 9 January 2006 on future patent policy in Europe,

- having regard to Rule 103(2) of its Rules of Procedure,

A. whereas the deficiencies of the Community patent proposals are unlikely to be resolved in the foreseeable future,

B. whereas an efficient, competitive and cost-effective patent system accessible to all is a key requirement of the Lisbon strategy for a competitive, knowledge-based society and crucial for the thriving of small and medium-sized enterprises as well as large companies,

C. whereas there have been growing concerns about undesirable patents in various fields and about a lack of democratic control over the processes by which such patents are granted, validated and enforced,

1. Urges the Commission to explore all possible ways of improving the patent and patent litigation systems in the EU, including participation in further discussions on the European Patent Litigation Agreement (EPLA) and accession to the Munich Convention, as well as revision of the Community patent proposals; as regards the EPLA, considers that the proposed text needs significant improvements, which address concerns about democratic control, judicial independence and litigation costs, and a satisfactory proposal for the Rules of Procedure of the EPLA Court;

2. Reminds the Commission that all legislative proposals should be accompanied by an in-depth impact analysis related to patent quality, governance of the patent system, judicial independence and litigation costs;

3. Requests that Parliament's Legal Service be asked to provide an interim opinion on EU-related aspects of the possible conclusion of the EPLA by Member States in the light of overlaps between the EPLA and the acquis communautaire and to clarify legislative competences in this field;

4. Instructs its President to forward this resolution to the Council, the Commission and the governments and parliaments of the Member States.

[1] OJ L 213, 30.7.1998, p. 13.

[2] Texts Adopted, P6_TA(2005)0407.

--------------------------------------------------
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 USC SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form
10-Q of Medallion Financial Corp. (the Company) for the quarter ending June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned hereby certifies, pursuant to 18
USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

(1) The Report
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.



|                                                  |  |                  
|------------------------------------------------- |  | -----------------
|By:                                               |  | /s/ Larry D. Hall
|Senior Vice President and Chief Financial Officer

Date: August 6, 2012
II

105TH CONGRESS

2D SESSION S. 1938

To suspend temporarily the duty on certain chemicals used in the formulation

of anti-cancer drugs.

IN THE SENATE OF THE UNITED STATES

APRIL 3, 1998

Mrs. FEINSTEIN (for herself and Mrs. BOXER) introduced the following bill;

which was read twice and referred to the Committee on Finance

A BILL

To suspend temporarily the duty on certain chemicals used

in the formulation of anti-cancer drugs.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. TEMPORARY SUSPENSION OF DUTY.

4 (a) IN GENERAL.—Subchapter II of chapter 99 of

5 the Harmonized Tariff Schedule of the United States is

6 amended by inserting in numerical sequence the following

7 new heading:

‘‘ 9902.32.15 4-Phenoxypyridine (CAS No.

4783–86–2) (provided for in

subheading 2933.39.61) ....... Free No change No change On or before

12/31/1999 ’’.
2

•S 1938 IS

1 (b) EFFECTIVE DATE.—The amendment made by

2 this section applies with respect to goods entered, or with3 drawn from warehouse for consumption, on or after the

4 15th day after the date of enactment of this Act.

Æ
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains financial information extracted from Balance Sheet,
Statement of Operations, Statement of Cash Flows and Notes thereto incorporated
in Part II, Item 7 of this Form 10-KSB and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-28-1998
<PERIOD-END>                               JUN-28-1998
<CASH>                                           4,924
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                24,182
<PP&E>                                          62,552
<DEPRECIATION>                                (60,023)
<TOTAL-ASSETS>                                  26,711
<CURRENT-LIABILITIES>                          861,984
<BONDS>                                              0
<PREFERRED-MANDATORY>                            9,325
<PREFERRED>                                          0
<COMMON>                                         2,394
<OTHER-SE>                                  11,573,570
<TOTAL-LIABILITY-AND-EQUITY>                 (915,273)
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               293,133
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              27,456
<INCOME-PRETAX>                              (373,589)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                               (373,589)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (373,589)
<EPS-PRIMARY>                                   (0.04)
<EPS-DILUTED>                                   (0.04)
        

</TABLE>
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 National Clonal Germplasm Repository: Corvallis, OR
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Plant Collections
                        Home
                                    Plant Collecting Expeditions
                                    Germplasm CGC Reports
                                    GRIN-Global
                                    Outreach
                                    Documents
                    USDASearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Corvallis, Oregon National Clonal Germplasm Repository People & Locations







Karol  Murarz

(Chuck)
                        National Clonal Germplasm Repository

                        




                        
                        Biological Science Aid
                        Phone: (541) 738-4200
                        
                        
                        Fax: (541) 738-4205(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                              28
<SECURITIES>                                         0
<RECEIVABLES>                                    1,488
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 2,289
<PP&E>                                           5,922
<DEPRECIATION>                                       0<F1>
<TOTAL-ASSETS>                                  10,202
<CURRENT-LIABILITIES>                            4,084
<BONDS>                                          1,466
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        300
<COMMON>                                             0
<OTHER-SE>                                       2,131
<TOTAL-LIABILITY-AND-EQUITY>                    10,202
<SALES>                                              0
<TOTAL-REVENUES>                                 7,411
<CGS>                                                0
<TOTAL-COSTS>                                    7,163
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 126
<INCOME-PRETAX>                                    244
<INCOME-TAX>                                        67
<INCOME-CONTINUING>                                177
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                           13
<NET-INCOME>                                       164
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>Not separately identified in the consolidated financial statements or
accompanying notes thereto.
</FN>


</TABLE>
IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF OREGON 

MEDFORD DIVISION 

JASON and DON LIBBY, 

Plaintiffs, 

vs. 

CITY OF MEDFORD et al., 

Defendants. 

AIKEN, Judge: 

No. I:! 5-cv-00298-CL 

ORDER 

On March 17, 2017, Magistrate Judge Clarke filed Findings and Recommendation ("F&R") 

recommending this Court grant defendants' motion for summary judgment. The F &R is now before 

me pursuant to 28 U.S.C. § 636(b) and Federal Rule of Civil Procedure 72. I review de novo those 

portions of the F&R to which objection is made. 28 U.S.C. § 636(b )(I )(C); Fed. R. Civ. P. 72(b )(3); 

Holder v. Holder, 392 F .3d I 009, I 022 (9th Cir. 2004). 

Following a de novo review, I find no error. I ADOPT Judge Clarke's F&R (doc. 67). 

Defendants' motions for summary judgment (docs. 33 & 42) are GRANTED. 

I -ORDER 
IT IS SO ORDERED. 

J/~ -ft(./ Dated this j_J[L day of~ 2017. 

MOJj 

Ann Aiken 

United States District Judge 

2-0RDER
United States Court of Appeals

for the Fifth Circuit

No. 20-40664

Summary Calendar

United States of America, 

Plaintiff—Appellee,

versus

Raul Pineda, 

Defendant—Appellant.

Appeal from the United States District Court

for the Eastern District of Texas

USDC No. 1:10-CR-70-5

Before Smith, Stewart, and Graves, Circuit Judges.

Per Curiam:*

In 2011 Raul Pineda, federal prisoner 64133-179, was convicted of one 

count of conspiring to possess with intent to distribute 500 grams or more of 

a substance containing methamphetamine, 50 grams or more of actual 

methamphetamine, and five kilograms or more of a substance containing a 

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

August 18, 2021

Lyle W. Cayce

Clerk

Case: 20-40664 Document: 00515983147 Page: 1 Date Filed: 08/18/2021
No. 20-40664

2

detectable amount of cocaine. He was sentenced to serve a within-guidelines 

term of 360 months in prison and a five-year term of supervised release. 

Now, he appeals the district court’s denial of his 18 U.S.C. § 3582(c)(2) 

motion for a sentence reduction, which was based on Amendment 782 to the 

Sentencing Guidelines. 

When considering a § 3582(c)(2) motion, the district court first asks 

whether the defendant is eligible for a reduction and the extent of the 

reduction authorized under U.S.S.G. § 1B1.10. Dillon v. United States, 560 

U.S. 817, 826-27 (2010). If the defendant is eligible for a reduction, then the 

court then asks whether, as a matter of discretion, one is warranted. Id. at 

827. The district court did not err when it determined that Pineda was 

ineligible for a reduction. Consequently, the judgment is AFFIRMED. 

Case: 20-40664 Document: 00515983147 Page: 2 Date Filed: 08/18/2021